Gennex Laboratories Ltd Financials
Company Logo

Gennex Laboratories Ltd Financial Statement

Gennex Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue23.79
Operating Expense18.41
Net Profit4.17
Net Profit Margin17.53
Earning Per Share0.18
EBIDTA5.38
Effective Tax Rate13.94

Gennex Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual66.80
Operating Expenses Annual54.38
Operating Profit Annual16.72
Interest Annual1.16
Depreciation0.81
Net Profit Annual11.80
Tax Annual2.96

Gennex Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning14.45
Cash Flow from Operations-33.43
Cash Flow from Investing0.93
Cash Flow from Financing79.01
Cash Flow at the End60.96

Gennex Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)22.59
PBIT Margin (%)21.50
PBT Margin (%)2.97
Net PROFIT Margin (%)15.94
Return On Networth / Equity (%)9.45
Return On Networth /Employed (%)12.50
Return On Assets (%)9.24
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)0.58

Gennex Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual15.83
Total Current Assets Annual178.99
Non Current Assets Annual26.35
Total Shareholders Funds Annual170.76
Total Assets Annual205.34

Gennex Laboratories Ltd Earning Calls

EPS (INR)

Expected

0.20

Reported

0.21

Surprise

5.00%

Mar 2024

EPS beaten by 5.00%

Dec 2023

EPS beaten by -20.00%

Sep 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 5, 2024, Gennex Laboratories Ltd has a market capitalization of 359.37 Cr. Value Research classifies it as a Small-Cap company.
Yes, Gennex Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.01.
In FY 2023 , Gennex Laboratories Ltd recorded a total revenue of approximately 66.80 Cr marking a significant milestone in the company's financial performance.
Gennex Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.7% and 0.0% annually, respectively..
Gennex Laboratories Ltd's current PE ratio is 30.46.
Gennex Laboratories Ltd's ROCE averaged 9.7% from the FY ending March 2022 to 2024, with a median of 9.2%. It peaked at 11.0% in March 2022, reflecting strong capital efficiency over the period..
Gennex Laboratories Ltd's latest EBIT is Rs. 15.91 Cr, surpassing the average EBIT of Rs. 9.71 Cr over the 5 years..